Paid Clinical Trials Toronto

Discover 1,997 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,997

Telemedicine Clinic for Prostate Cancer PatientsTelemedicine Clinic for Prostate Cancer Patients

Recruiting

Sponsor:

Grand River Hospital

Location:

Kitchener

Code:

NCT03413865

Conditions

Cancer, Treatment-Related

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Visits conducted via Telemedicine

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting

PHASE1

PHASE2

Sponsor:

Amgen

Location:

Toronto, Detroit MI, Ottawa, Indianapolis INshow 9 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab

INSIGHT (Insight Into Nephrotic Syndrome)INSIGHT (Insight Into Nephrotic Syndrome)

Recruiting

Sponsor:

The Hospital for Sick Children

Location:

Toronto, Scarborough, Brampton, Hamilton

Code:

NCT01605266

Conditions

Nephrotic Syndrome

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

A Study to Evaluate the Effect of Aficamten in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).A Study to Evaluate the Effect of Aficamten in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Recruiting

PHASE2

PHASE3

Sponsor:

Cytokinetics

Location:

Toronto, Detroit MI, Ann Arbor MI, Morristown NJshow 18 more

Code:

NCT06412666

Conditions

Pediatric

Symptomatic Obstructive Hypertrophic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Aficamten

Placebo

Use of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep ApneaUse of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep Apnea

Recruiting

Sponsor:

Centre for Sleep and Chronobiology, Canada

Location:

Toronto

Code:

NCT05954026

Conditions

Sleep Apnea, Obstructive

Sleep-Disordered Breathing

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

ExVent

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid TumorsA Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Marengo Therapeutics, Inc.

Location:

Toronto, Detroit MI, Columbus OH, New York NYshow 4 more

Code:

NCT05592626

Conditions

Advanced Solid Tumors

Genital Neoplasm, Female

Urogenital Neoplasms

Lung Neoplasm

Neoplasms by Site

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

STAR0602

Canadian Network for Autoimmune Liver DiseaseCanadian Network for Autoimmune Liver Disease

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Toronto, Hamilton, London, Kingstonshow 9 more

Code:

NCT03569826

Conditions

Primary Bilary Cirrhosis (PBC)

Autoimmune Hepatitis

Overlap Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Observational; no intervention

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM PatientsStudy of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

Recruiting

PHASE2

Sponsor:

Canadian Myeloma Research Group

Location:

Toronto, London

Code:

NCT05272826

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

Iberdomide

Bortezomib

Dexamethasone

Isatuximab

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGAnticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting

PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Toronto, London, Hermitage PA, Cleveland OHshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

Activity ,Smoking Cessation, Healthy Eating and Alcohol Intervention Program:(ACCELERATION)Activity ,Smoking Cessation, Healthy Eating and Alcohol Intervention Program:(ACCELERATION)

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT02264366

Conditions

Chronic Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Motivational Communication for Health Behavior management